The aberrantly expressed miR-372 partly impairs sensitivity to apoptosis in parathyroid tumor cells.

MLA

Verdelli, Chiara, et al. “The Aberrantly Expressed MiR-372 Partly Impairs Sensitivity to Apoptosis in Parathyroid Tumor Cells.” Endocrine-Related Cancer, vol. 25, no. 7, July 2018, pp. 761–71. EBSCOhost, https://doi.org/10.1530/ERC-17-0204.

APA

Verdelli, C., Forno, I., Morotti, A., Creo, P., Guarnieri, V., Scillitani, A., Cetani, F., Vicentini, L., Balza, G., Beretta, E., Ferrero, S., Vaira, V., & Corbetta, S. (2018). The aberrantly expressed miR-372 partly impairs sensitivity to apoptosis in parathyroid tumor cells. Endocrine-Related Cancer, 25(7), 761–771. https://doi.org/10.1530/ERC-17-0204

Chicago

Verdelli, Chiara, Irene Forno, Annamaria Morotti, Pasquale Creo, Vito Guarnieri, Alfredo Scillitani, Filomena Cetani, et al. 2018. “The Aberrantly Expressed MiR-372 Partly Impairs Sensitivity to Apoptosis in Parathyroid Tumor Cells.” Endocrine-Related Cancer 25 (7): 761–71. doi:10.1530/ERC-17-0204.